Keywords: r-pr, sales, fall, earnings, rise, franco-american, pharmaceutical
R-PR SALES FALL BUT EARNINGS RISE
Article | 04 May 1992
Franco-American pharmaceutical concern Rhone-Poulenc Rorer achieved an increase in net income for the first quarter of 1992 of 55.5% to $84 million, despite ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
